MedPath

Muscle Synergies During Gait in Children With Cerebral Palsy Undergoing Robot-assisted Gait Therapy

Not Applicable
Completed
Conditions
Cerebral Palsy
Interventions
Device: Robot-Assisted Gait Training
Registration Number
NCT06156969
Lead Sponsor
Spaulding Rehabilitation Hospital
Brief Summary

This is a single-arm longitudinal study for children with cerebral palsy with gait impairments that involves robot-assisted gait training (RGT) and includes pre and post-data collection visits. The study aims to evaluate changes in muscle synergies in children with Cerebral Palsy (CP) in response to RGT. Additionally, the study aims to investigate the relationship between muscle synergies and the clinical outcomes of RGT.

Detailed Description

Participants will be assessed 2 times - before and after training with the robot. All the testing and training sessions will be carried out at Spaulding Rehabilitation Hospital and will include:

Clinical tests:

* A test to evaluate gross motor function

* A test to assess walking speed

* A test to assess endurance

Muscle activity tests:

* A test to derive detailed measures of how well participant walk using a camera-based motion capture system.

* Special sensors (called electromyographic - EMG - sensors) will be used to determine when and how muscles are recruited to generate movements.

Training with the Robot:

Study participants will undergo 18 sessions of robot-assisted gait training for 18 time The training sessions will be carried out by trained study staff. The robot will assist study participants to walk. Each training session will last about 1 hour.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
19
Inclusion Criteria
  • Diagnosis of spastic cerebral palsy
  • 6 to 18 years of age
  • Gross Motor Function (GMFCS) Level I, II, III or IV
  • Femoral length < size of robotic exoskeleton used for gait training (femur length between 210-350mm)
  • Ability to communicate pain or discomfort
Exclusion Criteria
  • Recent use of Lokomat within the last 3 months
  • Contraindication to robotic-assisted gait training such us thromboembolic disease, progressive neurologic disorder, cardiovascular or pulmonary contraindications, aggressive behaviors, severe cognitive deficits, bone instabilities, fractures, osteoporosis)
  • Skin ulcers in trunk or lower limbs
  • Hip, knee, ankle arthrodesis

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Robot-assisted gait trainingRobot-Assisted Gait TrainingRobot-Assisted Gait Training using the LokomatPro device. Total of 18 training sessions, over a period of approximately 6-7 weeks. Sessions will last approximately 60 minutes.
Primary Outcome Measures
NameTimeMethod
Change in Cosine Similarity of the Muscle Synergies of the Most Affected Lower LimbData collected at baseline and at completion of the 7-week intervention

Surface electromyographic (EMG) data collected from 16 muscles of the lower limbs during overground gait will be analyzed using the non-negative matrix factorization technique to quantify the patterns of co-activation of muscles. Cosine similarity values will be estimated for the EMG recordings collected pre- and post-intervention. Cosine similarity values will range between 0 and 1, where 1 means that the patterns of co-activation are identical to normative whereas 0 means that they are completely different (as they do not overlap). The percentage of muscle synergies displaying an increase in cosine similarity will be reported.

Secondary Outcome Measures
NameTimeMethod
Change in Gross Motor Function Measure (GMFM) Dimension DData collected at baseline and at completion of the 7-week intervention

The GMFM Dimension D consists of a battery of thirteen motor tasks that the rater evaluates via visual observation of the motor behavior of the study participant. Dimension D of the scale is focused on standing function. Each item is scored on a 4-point ordinal scale from 0 to 3, where 0 indicates that the participant does not initiate the task; 1 indicates that the participant initiates the task; 2 indicates that the participant partially completes the task; and 3 indicates that the participant completes the task. The minimum value is 0, and the maximum value is 39. Higher values represent better function. The change from baseline to post-intervention is calculated by taking the difference between the value gathered post-intervention and the value gathered pre-intervention.

Percent Change in 6-Minutes Walk TestData collected at baseline and at completion of the 7-week intervention

Study staff will measure the distance walked by study participants during an interval of 6 min.

Percent Change in Edinburgh Visual Gait Scores (EVGS)Data collected at baseline and at completion of the 7-week intervention

The EVGS score is a standardized measure of gait quality derived using criteria based on visual observation of gait patterns in children with cerebral palsy. The EVGS includes 17 gait parameters and uses a three-point ordinal scale for each parameter, corresponding to normal, moderate, and severe deviation, respectively. The total score range is from 0 to 34 points, where 0 corresponds to normal gait and greater than 0 indicates gait abnormality.

Change in Gross Motor Function Measure (GMFM) Dimension EData collected at baseline and at completion of the 7-week intervention

The GMFM Dimension E consists of a battery of twenty-four motor tasks that the rater evaluates via visual observation of the motor behavior of the study participant. Dimension E of the scale is focused on walking function. Each item is scored on a 4-point ordinal scale from 0 to 3, where 0 indicates that the participant does not initiate the task; 1 indicates that the participant initiates the task; 2 indicates that the participant partially completes the task; and 3 indicates that the participant completes the task. The minimum value is 0, and the maximum value is 72. Higher values represent a better function. The change from baseline to post-intervention is calculated by taking the difference between the value gathered post-intervention and the value gathered pre-intervention.

Percent Change in 10-Meter Walk TestData collected at baseline and at completion of the 7-week intervention

Study staff will use a stopwatch to measure the time needed by study participants to cover a distance of 10 meters.

Trial Locations

Locations (1)

Spaulding Rehabilitation Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath